SunEdison, Inc. (NYSE:SUNE) shares moved up 17.11% in last trading session and ended the day at $1.78. SUNE Gross Margin is 17.60% and its has a return on assets of -7.30%. SunEdison, Inc. (NYSE:SUNE) quarterly performance is -50.14%.
On 4 March, SunEdison, Inc. (NYSE:SUNE) is planning to sell its equity stake in a 500 MW solar power project that it secured rights to develop in the state of Andhra Pradesh in India last year. The project, auctioned under the central government policy of National Solar Mission, will be the largest solar power project in India developed by a single company.
Everest Re Group Ltd. (NYSE:RE) ended the last trading day at $193.60. Company weekly volatility is calculated as 1.44% and price to cash ratio as 29.40. Everest Re Group Ltd. (NYSE:RE) showed a weekly performance of 3.60%.
Everest Re Group Ltd (NYSE:RE) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Friday, Analyst Ratings Network.com reports.
On 04 March, Donaldson Company, Inc. (NYSE:DCI) shares moved up 2.36% and was closed at $31.68. DCI EPS growth in last 5 year was 7.30%. Donaldson Company, Inc. (NYSE:DCI) year to date (YTD) performance is 11.19%.
On 2 March, Donaldson Company, Inc. (NYSE:DCI) said he expects adjusted earnings of $1.51 to $1.61 per share, off from the prior estimate of $1.49 to $1.69. Sales are expected to fall 5 to 7 percent, which is more than the 3 to 7 percent decline previously forecast.
Synalloy Corporation (NASDAQ:SYNL) shares moved down -1.17% in last trading session and ended the day at $8.46. SYNL Gross Margin is 15.60% and its has a return on assets of 5.20%. Synalloy Corporation (NASDAQ:SYNL) quarterly performance is 4.32%.
On 29 February, Synalloy Corporation (NASDAQ:SYNL) announced net sales from continuing operations for the fourth quarter of 2015 of $35.6 million. This represents a decrease of $13.0 million or 27% when compared to net sales from continuing operations for the fourth quarter of 2014. Net sales from continuing operations for the full-year 2015 were $175.5 million, down $24.0 million or 12% from 2014.
TherapeuticsMD, Inc. (NYSEMKT:TXMD) caters to the Healthcare space. Its weekly performance is 15.03%. On the last day of trading company shares ended up at $7.04. TherapeuticsMD, Inc. (NYSEMKT:TXMD) distance from 50-day simple moving average (SMA50) is -6.99%.
TherapeuticsMD, Inc. (NYSEMKT:TXMD) announced that the company will present detailed results from the phase 3 Rejoice Trial for its TX-004HR product candidate at separate upcoming investor and medical conferences. TX-004HR is an applicator-free vaginal estradiol softgel drug candidate for the treatment of moderate to severe vaginal pain during sexual intercourse (dyspareunia), a symptom of vulvar and vaginal atrophy (VVA) due to menopause.
Leave a Reply